Volume 12, Number 3—March 2006
Dispatch
Protease-resistant Prion Protein in Lymphoreticular Tumors of Variant Creutzfeldt-Jakob Disease Mice
Table
Experimental group | Postinfection interval (d) | Western blot (PrPres)* |
||
---|---|---|---|---|
Brain | Lymphoreticular tissue |
|||
Spleen | Lymph node | |||
Mice infected with vCJD agent | ||||
1* | 199 | + | + | +† |
2* | 199 | + | + | +† |
3 | 222 | + | + | Not done |
4* | 318 | + | + | + |
5 | 318 | + | + | Not done |
6 | 318 | + | + | Not done |
7 | 342 | + | + | Not done |
8* | 343 | + | + | + |
9 | 382 | + | + | Not done |
10 | 386 | + | + | Not done |
Control mice injected with 0.9% NaCl | ||||
1 | 405 | – | – | Not done |
2 | 405 | – | – | Not done |
3* | 321 | – | – | – |
4 | 405 | – | – | Not done |
*Widespread tumors of lymphoreticular tissue developed.
†Mouse also had PrPres in tumor involving thymus.
Page created: January 27, 2012
Page updated: January 27, 2012
Page reviewed: January 27, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.